NEACREST 20 MG BT 90

Treatment of hypercholesterolemia: Adults, teenagers, and children aged 6 years or more with pure hypercholesterolemia (type IIa including heterozygous familial hypercholesterolemia) or mixed dyslipidemia (type IIb) as a supplement to a diet when the response to diet and other non-pharmacological treatments (exercise, weight loss) is not sufficient. Homozygous familial hypercholesterolemia, in addition to a diet and other lipid-lowering treatments (including LDL apheresis) or when these treatments are not appropriate. Prevention of cardiovascular events.

Prevention of major cardiovascular events in patients estimated to be at high risk of having a first cardiovascular event, in addition to correcting other risk factors.